Skip to content

Remote Dietary Counseling to Promote Healthy Diet and Blood Pressure

Remote Dietary Counseling Using Web-based Tools to Promote Healthy Diet and Blood Pressure (Healthy BP)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03700710
Enrollment
187
Registered
2018-10-09
Start date
2019-01-16
Completion date
2021-06-30
Last updated
2021-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure, Dietary Modification, High Blood Pressure, Overweight and Obesity

Keywords

lifestyle modification, DASH diet, weight loss, exercise

Brief summary

American College of Cardiology/American Heart Association (ACC/AHA) hypertension guidelines recommend lifestyle modification for patients with elevated blood pressure. While eating a Dietary Approaches to Stop Hypertension (DASH)-type diet, increasing physical activity, and weight loss have been shown to reduce blood pressure, limited resources are available in the primary care setting to help patients make these changes. In this study, the investigators will compare the efficacy of a self-guided vs. dietitian-led approach using web-based lifestyle modification tools to reduce weight, improve dietary quality, and lower blood pressure in overweight/obese adults with elevated blood pressure.

Detailed description

Goals that all participants will be instructed to target include: 1) weight loss \>=3% at 3 months; 2) consume a healthier dietary pattern (high in fruits, vegetables, whole grains, low-fat dairy, vegetable/fish/poultry sources of protein, healthier sources of fat, and avoid sugar and salt); 3) reduce sodium intake to \<2300 mg/d; 4) at least 180 min/wk of moderate-intensity physical activity.

Interventions

BEHAVIORALSelf-Guided Approach

For a 12-week period, patients will be asked to access the web platform (Evolve, formerly BMIQ), review educational materials, and enter dietary information. From January 2019 to February 2021, participants used an earlier version of the platform, which was used in tandem with LoseIt (www.loseit.com), a meal-logging app that integrated with the platform. In February 2021, a platform update occurred (Evolve) where the core tenets of the program remained the same and included the dietary data entry directly on the platform.

BEHAVIORALDietitian-led Approach

For a 12-week period, patients will be asked to access the web platform (Evolve, formerly BMIQ), review educational materials, and enter dietary information. From January 2019 to February 2021, participants used an earlier version of the platform, which was used in tandem with LoseIt (www.loseit.com), a meal-logging app that integrated with the platform. In February 2021, a platform update occurred (Evolve) where the core tenets of the program remained the same and included the dietary data entry directly on the platform. Dietitians will access the web platform and provided personalized motivational interview phone calls on a weekly basis.

Sponsors

Geisinger Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 24-hour ambulatory SBP 120-160 mmHg * BMI ≥ 25 kg/m2 * Access to a telephone * Access to a computer or smartphone with internet access * Complete dietary data entry for at least 5 out of 7 days during run-in period * Enter weight into the platform during run-in period

Exclusion criteria

* Inability to understand English * Myocardial infarction, stroke, or atherosclerotic cardiovascular disease procedure within last 6 months. * Current treatment for malignancy * Planned or previous bariatric surgery * Pregnant, breast-feeding, or planned pregnancy prior to the end of participation * Self-reported average consumption of \> 21 alcoholic beverages per week or binge drinking. * Psychiatric hospitalization in past year * Current symptoms of angina * Planning to leave the area prior to end of the study * Current participation in another clinical trial * Principal investigator discretion (i.e. concerns about safety, compliance)

Design outcomes

Primary

MeasureTime frameDescription
Change in 24-hour Systolic Blood PressureBaseline to 12-week follow-upMeasured by 24-hour ambulatory blood pressure monitoring (SpaceLabs Ontrak)

Secondary

MeasureTime frameDescription
Change in 24-hour diastolic blood pressureBaseline to 12-week follow-upMeasured by 24-hour ambulatory blood pressure monitoring (SpaceLabs Ontrak)
Change in Daytime Systolic Blood PressureBaseline to 12-week follow-upMeasured by 24-hour ambulatory blood pressure monitoring (SpaceLabs Ontrak)
Change in Nighttime Systolic Blood PressureBaseline to 12-week follow-upMeasured by 24-hour ambulatory blood pressure monitoring (SpaceLabs Ontrak)
Change in Daytime Diastolic Blood PressureBaseline to 12-week follow-upMeasured by 24-hour ambulatory blood pressure monitoring (SpaceLabs Ontrak)
Change in Nighttime Diastolic Blood PressureBaseline to 12-week follow-upMeasured by 24-hour ambulatory blood pressure monitoring (SpaceLabs Ontrak)
Change in Waist CircumferenceBaseline to 12-week follow-upMeasured using a tape measure
Change in Physical Activity (metabolic equivalent of task [MET]-minute per weekBaseline to 12-week follow-upMeasured by International Physical Activity Questionnaire (IPAQ) Short Form
Change in Total Healthy Eating Index - 2015 scoreBaseline to 12-week follow-upAssessed by Viocare Food Frequency Questionnaire (score 0-100, 100=best possible score)
Change in WeightBaseline to 12-week follow-upWeight measured at baseline and 12-week visits without shoes

Other

MeasureTime frameDescription
Change in individual components of Healthy Eating Index scoreBaseline to 12-week follow-upEach individual component of the Healthy Eating Index score will be examined
Satisfaction with the Healthy BP Research Study12-week follow-up5-point Likert score

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026